221
Views
27
CrossRef citations to date
0
Altmetric
Review

Current management of parainfluenza pneumonitis in immunocompromised patients: a review

Pages 121-127 | Published online: 08 Aug 2012

References

  • HenricksonKJParainfluenza virusesClin Microbiol Rev200316224226412692097
  • HallCBRespiratory syncytial virus and parainfluenza virusN Engl J Med2001344251917192811419430
  • RihkanenHRonkkoENieminenTRespiratory viruses in laryngeal croup of young childrenJ Pediatr2008152566166518410770
  • StankovaJCarretASMooreDLong-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiencyPediatr Transplant200711220921317300503
  • MossRBSteigbigelRTSandersRLFangFPerspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patientsAdv Virol20112011910930 Epub July 7, 201122312357
  • BoeckhMThe challenge of respiratory virus infections in hematopoietic cell transplant recipientsBr J Haematol2008143445546718785968
  • MosconaAEntry of parainfluenza virus into cells as a target for interrupting childhood respiratory diseaseJ Clin Invest200511571688169816007245
  • NishinoRIkedaKHayakawaTTakahashiTSuzukiTSatoMSyntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1Bioorg Med Chem20111972418242721382718
  • MaoHThakurCSChattopadhyaySSilvermanRHGudkovABanerjeeAKInhibition of human parainfluenza virus type 3 infection by novel small moleculesAntiviral Res2008772839417964670
  • SpriggsMKMurphyBRPrinceGAOlmstedRACollinsPLExpression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunityJ Virol19876111341634232822951
  • HendersonFWPulmonary cell-mediated cytotoxicity in hamsters with parainfluenza virus type 3 pneumoniaAm Rev Respir Dis197912014147223482
  • HouSDohertyPCZijlstraMJaenischRKatzJMDelayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cellsJ Immunol19921494131913251354233
  • DaveVPAllanJESlobodKSViral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cellsVirology199419923763837510085
  • KarpDWillisJWilfertCMParainfluenza virus II and the immunocompromised hostAm J Dis Child197412745925934362486
  • DelageGBrochuPPelletierMJasminGLapointeNGiant-cell pneumonia caused by parainfluenza virusJ Pediatr1979943426429217981
  • MarcoliniJAMalikSSukiDWhimbeyEBodeyGPRespiratory disease due to parainfluenza virus in adult leukemia patientsEur J Clin Microbiol Infect Dis2003222798412627280
  • LewisVAChamplinREnglundJRespiratory disease due to parainfluenza virus in adult bone marrow transplant recipientsClin Infect Dis1996235103310378922798
  • WendtCHHertzMIRespiratory syncytial virus and parainfluenza virus infections in the immunocompromised hostSemin Respir Infect19951042242318668850
  • WhimbeyEChamplinRECouchRBCommunity respiratory virus infections among hospitalized adult bone marrow transplant recipientsClin Infect Dis19962257787828722930
  • VilchezRAMcCurryKDauberJThe epidemiology of parainfluenza virus infection in lung transplant recipientsClin Infect Dis200133122004200811702289
  • Lujan-ZilbermannJBenaimETongXSrivastavaDKPatrickCCDeVincenzoJPRespiratory virus infections in pediatric hematopoietic stem cell transplantationClin Infect Dis200133796296811528566
  • NicholsWGGooleyTBoeckhMCommunity-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experienceBiol Blood Marrow Transplant20017Suppl11S15S11777098
  • ChakrabartiSAviviIMackinnonSRespiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalityBr J Haematol200211941125113212472597
  • DeFabritusAMRiggioRRDavidDSSenterfitLBCheighJSStenzelKHParainfluenza type 3 in a transplant unitJAMA19792414384386214588
  • ChakrabartiSCollinghamKEHolderKFeganCDOsmanHMilliganDWPre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot studyBone Marrow Transplant200128875976311781627
  • ElizagaJOlavarriaEApperleyJGoldmanJWardKParainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatmentClin Infect Dis200132341341811170949
  • WendtCHWeisdorfDJJordanMCBalfourHHJrHertzMIParainfluenza virus respiratory infection after bone marrow transplantationN Engl J Med1992326149219261311800
  • DignanFAlvaresCRileyUParainfluenza type 3 infection post stem cell transplant: high prevalence but low mortalityJ Hosp Infect200663445245816772104
  • PeckAJEnglundJAKuypersJRespiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood200711051681168817502457
  • HodsonAKasliwalMStreetlyMMacMahonERajKA parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortalityBone Marrow Transplant201146121545155021258418
  • FrankJAJrWarrenRWTuckerJAZellerJWilfertCMDisseminated parainfluenza infection in a child with severe combined immunodeficiencyAm J Dis Child198313712117211746314807
  • LangeTFrankeGNiederwieserDParotitis associated with a parainfluenza virus type 3 infection during aplasia after unrelated allogeneic stem cell transplantationLeuk Lymphoma20064781714171516966297
  • ErardVChienJWKimHWAirflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory virusesJ Infect Dis2006193121619162516703503
  • HallCBMcBrideJTWalshEEAerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind studyN Engl J Med198330824144314476343860
  • SparrelidELjungmanPEkelof-AndstromERibavirin therapy in bone marrow transplant recipients with viral respiratory tract infectionsBone Marrow Transplant19971999059089156264
  • ChakrabartiSCollinghamKEHolderKOyaideSPillayDMilliganDWParainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapyClin Infect Dis20003161516151811096028
  • WrightJJO’DriscollGTreatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisoloneJ Heart Lung Transplant200524334334615737764
  • McIntoshKKurachekSCCairnsLMBurnsJCGoodspeedBTreatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosolAm J Dis Child198413833053086322573
  • MaoHChattopadhyaySBanerjeeAKN-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replicationVirology2009394114314819747707
  • ChenYBDriscollJPMcAfeeSLTreatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantationClin Infect Dis2011537e77e8021880586
  • Triana-BaltzerGBSandersRLHedlundMPhenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181J Antimicrob Chemother2011661152821097900
  • WatanabeMMishinVPBrownSAEffect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in miceAntimicrob Agents Chemother20095393942395119564364
  • AlymovaIVWatanabeMBoydKLChandPBabuYSPortnerAEfficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice – further evaluationAntivir Ther200914789189819918093
  • PasteyMKGowerTLSpearmanPWCroweJEJrGrahamBSA RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3Nat Med200061354010613821
  • LambertDMBarneySLambertALPeptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusionProc Natl Acad Sci U S A1996935218621918700906
  • ZhaoHDeBPDasTBanerjeeAKInhibition of human parainfluenza virus-3 replication by interferon and human MxAVirology199622023303388661384
  • OttoliniMGHemmingVGPiazzaFMJohnsonSADarnellMEPrinceGATopical immunoglobulin is an effective therapy for parainfluenza type 3 in a cotton rat modelJ Infect Dis199517212432457797921
  • OttoliniMGPorterDDBlancoJCPrinceGAA cotton rat model of human parainfluenza 3 laryngotracheitis: virus growth, pathology, and therapyJ Infect Dis2002186121713171712447755
  • PrinceGAPorterDDTreatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroidJ Infect Dis199617335986088627023